Prescribing for a patient with reduced intestinal length
Australian Prescriber · 01.08.2013 · 36 (4) · 136-138
DOI: 10.18773/austprescr.2013.048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian Prescriber, erschienen am 01.08.2013. Verfasst von Siddharth Sood und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Surgical interventions involving the gut may result in either a temporary or, in some cases, permanent stoma.If a significant length of small intestine has been resected, there may be impaired drug absorption.Many factors, including the underlying disease, influence drug absorption after bowel resection.The drug dose or formulation may need to be modified to improve bioavailability.Pharmacists can advise on formulations.Specialist advice from a multidisciplinary intestinal rehabilitation unit may be needed in cases of short gut syndrome.absorption.The large intestine has a minimal role in drug absorption, primarily confined to slow-release drugs or drugs where the primary effect is in the large intestine (such as 5-aminosalicylates).Plasma drug concentration is dependent on bioavailability which reflects the rate and extent of drug absorption into the systemic circulation.Many factors that are particularly relevant to patients following intestinal resections can have a profound influence on drug absorption (Box). 2 Intestinal lengthThe most significant influence on drug absorption in the gastrointestinal tract is the surface area of the lumen.This can be of particular concern, especially if repeated resections have reduced the length of remaining small intestine.It can be difficult to assess how much small intestine remains in some patients and radiology is known to be misleading.In most patients the length of the remaining small bowel can only be estimated by reviewing previous operative reports.Key lengths of residual small intestine are listed in the Table .An intact ileocaecal valve and the presence of a colon improves function.3 Patients with less than these lengths are at risk of short gut syndrome, which results in compromised absorption of not only drugs, but also fluids, macro-and micronutrients.These patients universally have altered drug absorption, but in most cases are co-managed with an experienced gastroenterologist or intestinal rehabilitation centre.Some will require parenteral nutrition to survive. Presence of a stomaPatients with a colostomy are unlikely to suffer significant problems with drug absorption as most drugs are absorbed in the small intestine.Normal
Zitieren
APA
Sood, S., Tanner, F., & Testro, A. (2013). Prescribing for a patient with reduced intestinal length. Australian Prescriber, 36(4), 136-138. https://doi.org/10.18773/austprescr.2013.048
Vancouver
Sood S, Tanner F, Testro A. Prescribing for a patient with reduced intestinal length. Australian Prescriber. 2013;36(4):136-138. doi:10.18773/austprescr.2013.048
BibTeX
@article{Sood2013,
author = {Sood, Siddharth and Tanner, Francine and Testro, Adam},
title = {Prescribing for a patient with reduced intestinal length},
journal = {Australian Prescriber},
year = {2013},
volume = {36},
number = {4},
pages = {136--138},
doi = {10.18773/austprescr.2013.048}
}
EUVIMED